John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Dutch Bros
BROS
$6.88B
| $43.1M | 0.1% |
1,306,345
+1,167,605
| +842% | +$34.5M |
|
252
PUT
Wayfair
W
$13.9B
| $43.1M | 0.1% |
634,800
+31,200
| +5% | +$1.76M |
|
253
CNX Resources
CNX
$5.38B
| $43M | 0.1% |
1,812,883
+366,229
| +25% | +$7.6M |
|
254
Sun Life Financial
SLF
$44B
| $42.6M | 0.1% |
+780,981
| New | +$41.3M |
|
255
PUT
Lumentum
LITE
$77.7B
| $42.3M | 0.1% |
893,300
-87,500
| -9% | -$4.45M |
|
256
iShares Biotechnology ETF
IBB
$10.7B
| $42.2M | 0.1% |
+307,207
| New | +$42M |
|
257
Jacobs Solutions
J
$17.6B
| $41.8M | 0.1% |
329,065
+84,186
| +34% | +$9.87M |
|
258
Toronto Dominion Bank
TD
$194B
| $41.4M | 0.1% |
+685,337
| New | +$41.4M |
|
259
Howmet Aerospace
HWM
$108B
| $41.4M | 0.1% |
604,368
+236,066
| +64% | +$14.5M |
|
|
CNH
260
CNH Industrial
CNH
$19.1B
| $41M | 0.1% |
3,166,061
-4,722,169
| -60% | -$57.1M |
|
261
Shell
SHEL
$257B
| $40.7M | 0.1% |
606,506
+580,506
| +2,233% | +$37.2M |
|
262
Royalty Pharma
RPRX
$27.3B
| $39.6M | 0.09% |
1,303,659
-807,609
| -38% | -$23.8M |
|
263
NOV
NOV
$7.28B
| $38.9M | 0.09% |
1,993,556
+1,858,600
| +1,377% | +$34.6M |
|
264
StoneCo
STNE
$2.16B
| $38.8M | 0.09% |
2,335,937
-2,252,373
| -49% | -$38.6M |
|
265
Amdocs
DOX
$6.41B
| $38.3M | 0.09% |
423,617
+146,204
| +53% | +$13.3M |
|
266
Globus Medical
GMED
$11.7B
| $38.3M | 0.09% |
713,315
-17,273
| -2% | -$929K |
|
267
Toast
TOST
$21.2B
| $38.2M | 0.09% |
1,532,480
-1,416,645
| -48% | -$29.3M |
|
268
Invesco
IVZ
$14.1B
| $38.2M | 0.09% |
2,301,734
+946,723
| +70% | +$15.3M |
|
269
Wendy's
WEN
$1.72B
| $38.1M | 0.09% |
2,024,243
-320,088
| -14% | -$6.02M |
|
270
PUT
Starwood Property Trust
STWD
$6.06B
| $37.9M | 0.09% |
1,864,900
+162,900
| +10% | +$3.3M |
|
271
Agree Realty
ADC
$9.19B
| $37.8M | 0.09% |
661,694
+535,374
| +424% | +$31.4M |
|
272
Waste Management
WM
$89.6B
| $37.5M | 0.09% |
176,007
-171,067
| -49% | -$33.6M |
|
273
Stellantis
STLA
$20.4B
| $37.2M | 0.09% |
1,313,689
-473,075
| -26% | -$11.8M |
|
274
Delek US
DK
$4.38B
| $36.7M | 0.09% |
1,194,562
+160,069
| +15% | +$4.33M |
|
275
Tandem Diabetes Care
TNDM
$1.55B
| $36.2M | 0.08% |
1,021,993
+320,639
| +46% | +$8.59M |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.